(Medical Corporation) Aeba Kai | TSR Bulletin | Bankruptcy and Noteworthy Company Information – Tokyo Shoko Research

News Highlights

Medical Corporation Aeba Kai has gone bankrupt. According to TSR Bulletin, the corporation’s current ratio deteriorated to 0.7x in the fiscal year ending December 2023, and its medical business profit margin had been in deficit for consecutive periods. This situation suggests that if they had consulted with specialists early on, the option of business succession through M&A might have remained available. In the case of M&A under sound financial conditions, it is conceivable that there would have been room for negotiation to release the director’s personal joint and several liability. Choosing succession over closure would have led to the continuation of regional medical care and provided a safety net for patients and staff.

Perspective from the M&A Medical Editorial Department

The bankruptcy of Medical Corporation Aeba Kai can be described as a typical example of being “too late” in healthcare institution management. The figures from the fiscal year ending December 2023, with a current ratio of 0.7x and consecutive deficits in medical business profit margin, indicate that the warning lights were not just yellow, but flashing red. Had they consulted with business succession and M&A specialists at this stage, it is highly probable that they could have secured a path for “business succession,” which is the route that healthcare institutions facing a lack of successors or management difficulties should take, rather than simply closing down. In particular, conditions such as the “release of the director’s personal joint and several liability,” which could have been negotiated precisely because of sound financial management, mean that all negotiation power is lost after bankruptcy. While the specific circumstances leading Aeba Kai to this state are unknown, this case serves as a stark reminder of how crucial early consultation with specialists is, even to minimize the impact on regional medical care.

Points Raised by This News

• Deteriorating management indicators, such as a current ratio of 0.7x and consecutive deficits in medical business profit margin, strongly suggest that the timing for considering business succession M&A was missed.
• In a state on the verge of bankruptcy, negotiating conditions in M&A, such as the “release of the director’s personal joint and several liability,” becomes impossible.
• From the perspective of continuing regional medical care and securing a safety net for patients and staff, the importance of business succession through M&A, rather than closure, is highlighted.
• The case of Aeba Kai demonstrates the risks of continuing business operations while burdened with the personal joint and several liability risk.

Practical Questions Arising from This News

• What kind of specialists did Aeba Kai consult with when signs of management deterioration became apparent?
• Given the situation of a 0.7x current ratio and consecutive deficits in medical business profit margin, what was the likelihood of business succession through M&A?
• What would have been the impact on regional medical care and staff employment by choosing business succession instead of closure?

If You Feel “Should I Consult Too?”

If your institution is experiencing a continued decline in medical business profit margin, or if your current ratio remains below 1x, it may be time to consider business succession M&A. After bankruptcy, it becomes difficult even to find a safety net for patients and staff. We recommend consulting with a medical M&A specialist as soon as possible to gather information on the options available in your current situation.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as a certified M&A support institution by the Small and Medium Enterprise Agency. We handle consultations with strict confidentiality. Free consultations are available here.